天能動力(00819.HK)四家策略投資者已認購分拆公司合共1,430萬股新股
天能動力(00819.HK)早前曾公布有關建議分拆及建議A股上市的消息。
現宣布,上周三(6月26日),分拆公司已同意發行及四家策略投資者已同意認購分拆公司合共1,430萬股新股,佔分拆公司經擴大股本的1.67%。策略投資認購事項的認購價格為每股分拆公司股份12.8元人民幣(下同),致使分拆公司的投後估值為約109.5億元。
此外,策略投資認購事項可透過於分拆集團的發展及業務營運中引入外部監管措施,藉以改善分拆公司的企業管治架構,有助確保公司及股東的整體利益。
現時,分拆公司合共有8.56億股已發行股份,及為公司擁有96.7%權益的間接非全資附屬公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.